Edition:
United States

Quest Diagnostics Inc (DGX)

DGX on New York Consolidated

85.75USD
18 Apr 2019
Change (% chg)

$0.05 (+0.06%)
Prev Close
$85.70
Open
$85.78
Day's High
$86.56
Day's Low
$84.32
Volume
1,486,535
Avg. Vol
1,305,411
52-wk High
$116.49
52-wk Low
$78.95

Latest Key Developments (Source: Significant Developments)

Quest Diagnostics CEO's Total 2018 Compensation Was $10 Mln Versus $10.3 Mln In 2017
Wednesday, 3 Apr 2019 08:54am EDT 

April 3 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS INC - CEO STEPHEN RUSCKOWSKI'S TOTAL 2018 COMPENSATION WAS $10 MILLION VERSUS $10.3 MILLION IN 2017.QUEST DIAGNOSTICS INC - 2018 MEDIAN EMPLOYEE TO CEO PAY RATIO WAS ESTIMATED TO BE APPROXIMATELY 1 TO 213..  Full Article

Quest Diagnostics Prices $500 Million Of Senior Notes
Thursday, 7 Mar 2019 05:37pm EST 

March 7 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS PRICES $500 MILLION OF SENIOR NOTES.QUEST DIAGNOSTICS INC - A PUBLIC OFFERING OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 4.200% SENIOR NOTES DUE 2029.  Full Article

Quest Diagnostics Inc Files For Offering Of Senior Notes Due 2029
Thursday, 7 Mar 2019 09:23am EST 

March 7 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS INC FILES FOR OFFERING OF UP TO $500 MILLION OF SENIOR NOTES DUE 2029 - SEC FILING.QUEST DIAGNOSTICS INC SAYS NOTES WILL BE ISSUED IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 IN EXCESS THEREOF.  Full Article

Quest Diagnostics-Raises Dividend By 6 Pct To An Annual Rate Of $2.12 Per Share
Wednesday, 28 Nov 2018 05:34pm EST 

Nov 28 (Reuters) - Quest Diagnostics Inc ::RAISES DIVIDEND BY 6% TO AN ANNUAL RATE OF $2.12 PER SHARE.2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.57 BILLION.CASH PROVIDED BY OPERATIONS NOW EXPECTED TO APPROXIMATE $1.25 BILLION IN 2018.QUEST DIAGNOSTICS - 2018 REPORTED DILUTED EPS EXPECTED TO BE GREATER THAN $5.34, ADJUSTED DILUTED EPS EXPECTED TO BE GREATER THAN $6.30.FY2018 EARNINGS PER SHARE VIEW $6.56, REVENUE VIEW $7.62 BILLION -- REFINITIV IBES DATA.  Full Article

Quest Diagnostics to build flagship laboratory at Visionary Campus in Clifton
Wednesday, 28 Nov 2018 06:45am EST 

Nov 28 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO BUILD FLAGSHIP LABORATORY AT VISIONARY CAMPUS IN CLIFTON, NEW JERSEY TO EMPOWER BETTER HEALTH FOR PATIENTS IN SEVEN STATES.QUEST DIAGNOSTICS - NEW LABORATORY WILL EMPLOY MORE THAN 1,100 PEOPLE.QUEST DIAGNOSTICS INC - NEW LABORATORY IS EXPECTED TO BE OPERATIONAL IN EARLY 2021.  Full Article

Quest Diagnostics To buy Laboratory Services Business Of Boyce And Bynum Pathology Laboratories
Tuesday, 27 Nov 2018 09:00am EST 

Nov 27 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE THE LABORATORY SERVICES BUSINESS OF BOYCE AND BYNUM PATHOLOGY LABORATORIES, EXPANDING DIAGNOSTIC INNOVATION IN THE MIDWEST.QUEST DIAGNOSTICS INC - ADDITIONAL FINANCIAL TERMS OF TRANSACTION WERE NOT DISCLOSED..  Full Article

Quest Diagnostics Reports Q3 Reported Diluted EPS Of $1.53
Tuesday, 23 Oct 2018 06:45am EDT 

Oct 23 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.THIRD QUARTER REVENUES OF $1.89 BILLION, UP 1.8% FROM 2017.UPDATES OUTLOOK FOR FULL-YEAR 2018.THIRD QUARTER REPORTED DILUTED EPS OF $1.53.SEES FY 18 REPORTED DILUTED EPS NOW EXPECTED TO BE BETWEEN $5.57 AND $5.64.THIRD QUARTER ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION OF $1.68.SEES FY 2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.62 BILLION.SEES FY 18 ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION EXPENSE NOW EXPECTED TO BE BETWEEN $6.53 AND $6.60.  Full Article

Oxford Immunotec Sells U.S. Lab Services Business For $170 Mln To Quest Diagnostics - SEC Filing
Tuesday, 25 Sep 2018 10:35am EDT 

Sept 25 (Reuters) - Quest Diagnostics Inc ::OXFORD IMMUNOTEC GLOBAL PLC - TO SELL ITS U.S. LABORATORY SERVICES BUSINESS FOR GROSS PROCEEDS OF $170 MILLION IN CASH TO QUEST DIAGNOSTICS - SEC FILING.OXFORD IMMUNOTEC GLOBAL PLC - WILL UPDATE FULL YEAR 2018 REVENUE GUIDANCE UPON CLOSING OF TRANSACTION.  Full Article

Quest To Acquire U.S. Laboratory Services Business Of Oxford Immunotec
Tuesday, 25 Sep 2018 09:00am EDT 

Sept 25 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE U.S. LABORATORY SERVICES BUSINESS OF OXFORD IMMUNOTEC.QUEST DIAGNOSTICS INC - PARTIES EXPECT TO ENTER INTO A STRATEGIC COLLABORATION AGREEMENT TO DRIVE CONTINUED GROWTH OF T-SPOT.TB TESTING IN U.S.QUEST DIAGNOSTICS INC - INTENDS TO CONTINUE TO OFFER QUANTIFERON TB BLOOD TESTING SERVICES TO PROVIDE PHYSICIANS CHOICE IN BLOOD-BASED TB TESTING.QUEST DIAGNOSTICS - OXFORD IMMUNOTEC TO SELL T-SPOT.TB TEST KITS & RELATED ACCESSORIES TO CO UNDER TERMS OF A LONG-TERM SUPPLY AGREEMENT.  Full Article

Quest Diagnostics Acquires Reprosource
Monday, 24 Sep 2018 09:00am EDT 

Sept 24 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS ACQUIRES REPROSOURCE, EXTENDING INTO ADVANCED FERTILITY DIAGNOSTICS.QUEST DIAGNOSTICS INC - ADDITIONAL TERMS WERE NOT DISCLOSED..  Full Article